EUVIMEDEUVIMED entdecken
Crossref

Platelets and monocytes: A dynamic duo aiding in the prediction of the clinical response to thrombopoietin receptor agonists in immune thrombocytopenia?

Rick Kapur iD

British Journal of Haematology · 2025

DOI: 10.1111/bjh.19991 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, 2025. Verfasst von Rick Kapur. Beteiligte Einrichtung: Sanquin Research, Department of Experimental Immunohematology, Amsterdam and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterda…. Hauptthemen laut MEDLINE: Blood Platelets, Monocytes, Receptors, Thrombopoietin, Purpura, Thrombocytopenic, Idiopathic. Die Arbeit nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with immune thrombocytopenia (ITP) suffer from an autoimmune bleeding disorder with an isolated low number of platelets. Platelets and megakaryocytes are targeted by the immune system, due to a loss of immune tolerance, via the action of platelet‐autoantibodies and/or cytotoxic T cells. ITP is a highly variable disorder regarding the underlying biological mechanisms, disease trajectories and treatment responses. Predictive indicators are therefore strongly warranted. To analyze the predictive response to the thrombopoietin receptor agonist eltrombopag, in this issue of the British Journal of Haematology, Osuna‐Gomez and co‐workers research platelet‐leukocyte complexes in 38 ITP patients upon treatment with eltrombopag. Elevated platelet counts upon treatment with eltrombopag were associated with increased complexes of platelets bound to leucocytes. A higher percentage of monocytes bound to platelets, with an increased IL‐10 production in monocytes, was found to be associated to a favorable clinical response to treatment with eltrombopag. Further validation is required but these findings reveal the potential of analyzing platelet‐monocyte complexes as a predictive indicator for the clinical response to eltrombopag in patients with ITP. Commentary on: Osuna‐Gómez et al. Interplay of leucocyte‐platelet complexes and clinical response to eltrombopag in immune thrombocytopenia patients. Br J Haematol 2025; 206:1200‐1212.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood PlateletsMonocytesReceptors, ThrombopoietinPurpura, Thrombocytopenic, IdiopathicBenzoatesHydrazinesPyrazolesInterleukin-10Platelet CountHumansImmunomodulation

Stichwörter der Autor:innen

eltrombopagimmune thrombocytopeniaplatelet–leucocyteplatelet–monocytethrombopoietin receptor agonists

Substanzen

Receptors, ThrombopoietineltrombopagBenzoatesHydrazinesPyrazolesInterleukin-10

Autor:innen und Institutionen

  • Sanquin Research, Department of Experimental Immunohematology, Amsterdam and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

ORCID-Profile: Rick Kapur

Zitieren

APA

Kapur, R. (2025). Platelets and monocytes: A dynamic duo aiding in the prediction of the clinical response to thrombopoietin receptor agonists in immune thrombocytopenia?. British Journal of Haematology. https://doi.org/10.1111/bjh.19991

Vancouver

Kapur R. Platelets and monocytes: A dynamic duo aiding in the prediction of the clinical response to thrombopoietin receptor agonists in immune thrombocytopenia?. British Journal of Haematology. 2025. doi:10.1111/bjh.19991

BibTeX
@article{Kapur2025,
  author = {Kapur, Rick},
  title = {Platelets and monocytes: A dynamic duo aiding in the prediction of the clinical response to thrombopoietin receptor agonists in immune thrombocytopenia?},
  journal = {British Journal of Haematology},
  year = {2025},
  doi = {10.1111/bjh.19991}
}
Kostenlos starten →